Donna Godward

Chief Quality Officer at Carmell Therapeutics

Donna Godward retired from Johnson & Johnson in 2016 where she served as Chief Quality Officer, Medical Devices & Diagnostics (MD&D) from 2010-2016. As Chief Quality Officer, Ms. Godward provided strategic direction and oversight for all areas of quality and regulatory compliance across the global MD&D business sector. She partnered with senior business leaders to assure end-to-end quality and regulatory compliance, from development through manufacturing, distribution and end-customer use. As a member of the Quality & Compliance Leadership Team, she was responsible for recommending policy and developing standards across Johnson & Johnson. Prior to this role, Ms. Godward served as Worldwide Vice President of Regulatory, Quality & Compliance for the Cordis franchise, with responsibility for quality assurance, regulatory affairs, regulatory compliance and healthcare compliance.

During her tenure, Ms. Godward built strong partnerships with operations and R&D to improve effectiveness in new product development and launches, and strengthened the global capability of the function. A leader in quality leadership development, Ms. Godward also was instrumental in helping to create the Johnson & Johnson Executive Quality Leadership Development Program. She also served as co-chair of the Johnson & Johnson Global Quality Council and as a member of the Johnson & Johnson Supply Chain Council. Ms. Godward joined Johnson & Johnson in 2000 as Executive Director, Quality, Regulatory & Compliance, for Ortho-Clinical Diagnostics, Inc. (OCD). She later assumed the role of Worldwide Vice President of Quality, Regulatory & Compliance for OCD, with responsibility for quality systems, regulatory affairs and compliance for all manufacturing sites and products worldwide. Prior to joining Johnson & Johnson, Ms. Godward held positions in quality, regulatory and operations with Merck, Bristol Myers Squibb and Steris Corporation. She earned a B.A. in Biological Sciences from Indiana University and an MBA from Washington University.


Org chart

No direct reports

Teams


Offices

This person is not in any offices


Carmell Therapeutics

Carmell develops technology for producing biologically-active plastics from blood plasma for treating bone and connective tissue injuries.


Employees

11-50

Links